HyTest Web Store uses cookies to improve user experience.

Thrombin activatable fibrinolysis inhibitor (TAFI) Cat.#

8TA1

Data Sheet

This data sheet is provided for information only. After adding the product to the cart by clicking the button below you will see if there is a volume discount available.

Sign up or login to see prices and to request offers
Loading...
Loading MAbs
Properties
Cat.#

8TA1

Source:

Human plasma.

Plasma samples from donors were tested and found negative for HbsAg, HIV-1 and HIV-2 antibodies, HCV, and syphilis

Application:

Immunological and mass TAFI standard.

TAFI (synonyms: procarboxypeptidase B, carboxypeptidase U, carboxypeptidase R) is a plasma protein circulating as a zymogen. Being activated by thrombin-thrombomodulin complex during blood coagulation, it exerts carboxypeptidase activity. It splits out C-terminal lysine from fibrin and prevents fibrin lysis by plasmin. TAFI is considered as a risk factor for cardiovascular diseases.

Analysis:

Purity > 90 %

(SDS-PAGE). Protein concentration determined by the Lowry procedure.

Presentation:

Frozen in 10mM Tris-HCl buffer, pH 7.5, containing 0.15 M NaCl.

Storage:

-20 °C (-15 … -30 °C allowed)

Material safety note:

This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

References:

See all TAFI References

Download datasheet as a PDF file below
Look for similar items